BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8184813)

  • 21. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.
    De Vecchis R; Di Biase G; Ariano C; Cioppa C; Giasi A; Ciccarelli A; Pucciarelli A; Cantatrione S
    Arq Bras Cardiol; 2011 Dec; 97(6):507-16. PubMed ID: 22001954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Dickstein K; Manhenke C; Aarsland T; Køpp U; McNay J; Wiltse C
    Am J Cardiol; 1999 Jun; 83(12):1638-44. PubMed ID: 10392868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
    Rouleau JL; Pfeffer MA; Stewart DJ; Isaac D; Sestier F; Kerut EK; Porter CB; Proulx G; Qian C; Block AJ
    Lancet; 2000 Aug; 356(9230):615-20. PubMed ID: 10968433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
    O'Grady MR; Minors SL; O'Sullivan ML; Horne R
    J Vet Intern Med; 2008; 22(4):897-904. PubMed ID: 18537880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for acute renal insufficiency induced by diuretics in patients with congestive heart failure.
    Sun WY; Reiser IW; Chou SY
    Am J Kidney Dis; 2006 May; 47(5):798-808. PubMed ID: 16632018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group.
    Colfer HT; Ribner HS; Gradman A; Hughes CV; Kapoor A; Laidlaw JC
    Am J Cardiol; 1992 Aug; 70(3):354-8. PubMed ID: 1632402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of routine investigations to predict loop diuretic down-titration success in stable heart failure.
    Martens P; Verbrugge FH; Boonen L; Nijst P; Dupont M; Mullens W
    Int J Cardiol; 2018 Jan; 250():171-175. PubMed ID: 29056238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Stevenson LW; Bellil D; Grover-McKay M; Brunken RC; Schwaiger M; Tillisch JH; Schelbert HR
    Am J Cardiol; 1987 Sep; 60(8):654-8. PubMed ID: 3661430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diuretic therapy in acute heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
    Gheorghiade M; Gattis WA; O'Connor CM; Adams KF; Elkayam U; Barbagelata A; Ghali JK; Benza RL; McGrew FA; Klapholz M; Ouyang J; Orlandi C;
    JAMA; 2004 Apr; 291(16):1963-71. PubMed ID: 15113814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure.
    Pellicori P; Cleland JG; Zhang J; Kallvikbacka-Bennett A; Urbinati A; Shah P; Kazmi S; Clark AL
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):599-609. PubMed ID: 27819111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of M-mode echocardiography in patients with congestive heart failure.
    Baker BJ; Leddy C; Galié N; Casebolt P; Franciosa JA
    Am Heart J; 1986 Apr; 111(4):697-702. PubMed ID: 3953392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    Tyni-Lenné R; Gordon A; Jansson E; Bermann G; Sylvén C
    Am J Cardiol; 1997 Oct; 80(8):1025-9. PubMed ID: 9352972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
    Feldman AM; Baughman KL; Lee WK; Gottlieb SH; Weiss JL; Becker LC; Strobeck JE
    Am J Cardiol; 1991 Nov; 68(11):1203-10. PubMed ID: 1951080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indications and effects of captopril therapy in childhood.
    Bendig L; Temesvári A
    Acta Physiol Hung; 1988; 72 Suppl():121-9. PubMed ID: 3075397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy.
    Grassi G; Seravalle G; Bertinieri G; Turri C; Stella ML; Scopelliti F; Mancia G
    Clin Sci (Lond); 2001 Aug; 101(2):141-6. PubMed ID: 11473487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
    Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.